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results for Japanese encephalitis vi-
rus–speciﬁ  c IgM. Of the 11 patients, 
10 had no history of travel to India or 
other dengue-endemic countries. DF or 
DHF was initially diagnosed for 7 pa-
tients, and viral encephalitis, typhoid 
fever, or viral fever was diagnosed for 
others without serologic tests. Reverse 
transcription–PCR and virus isolation 
were performed at Institute of Tropi-
cal Medicine, Nagasaki University, 
Nagasaki, Japan, but the dengue virus 
genome was not detected, and no virus 
was isolated, likely because sample 
collection was delayed and the sample 
was transported to Japan in a deterio-
rated condition.
DF/DHF have been considered 
to be a possible public health threat 
to Nepal because DF/DHF epidemics 
have occurred recently in India and 
Pakistan, which reported several thou-
sand cases and >100 deaths (6). The 
ﬁ  rst DF case in Nepal was reported 
in 2004 (7). Further, the ﬁ  rst DENV-
2 strain of Nepal origin was isolated 
from a Japanese traveler who visited 
Nepal and in which DF developed af-
ter the patient returned to Japan. The 
isolated DENV-2 (GenBank accession 
no. AB194882) was 98% homologous 
with DENV-2 isolated in India (8). The 
prevalence of dengue virus antibody 
was reported to be 10.4% in the south-
western region of Nepal (9). These 
reports suggest that dengue virus has 
been circulating in Nepal for several 
years. Thus, DF/DHF has likely been 
misdiagnosed and illness caused by 
dengue virus underestimated in Ne-
pal. In contrast, Japanese encephali-
tis has been a public health problem 
in southwestern region of Nepal, and 
large epidemics have occurred almost 
every year since 1978 (10). Nepal has 
no dengue surveillance programs, and 
health professionals do not usually 
consider dengue as a differential diag-
nosis.
The emergence occurred in the 
lowland Terai belt region, which bor-
ders the state of Bihar, India. The Ae-
des mosquito is known to persist in 
this region. The emerging DENV-2 
is likely to have been introduced into 
Nepal from India.
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Human 
Tuberculosis 
Caused by 
Mycobacterium 
bovis, Taiwan 
To the Editor:  Mycobacterium 
bovis is one of the causative agents 
of tuberculosis (TB) in humans and 
animals. Drinking unpasteurized milk, 
eating undercooked meat, and close 
contact with infected animals are the 
main sources of infection for humans. 
Currently, 119 M. bovis spoligotypes 
are contained in the fourth internation-
al spoligotyping database (SpolDB 4) 
and are categorized into 3 main sublin-
eages corresponding to ST prototypes 
482, 683, and 479 (1). 
Although an M. bovis surveillance 
program for farm animals has been 
implemented by the Taiwan Council 
of Agriculture, no surveillance system 
exists for human TB cases caused by 
M. bovis. To monitor the epidemiol-
ogy of M. bovis in domestic animals, 
a regular tuberculin skin test (TST) 
is compulsory for cattle and sheep 
and optional for deer in Taiwan (2). 
In 2005, screening of Mycobacterium 
spp. infections by TST was performed 
for 111,412 cattle and 73,396 caprint 
and ovine herds, of which 188 (0.17%) 
and 148 (0.2%), respectively, were 
positive (2). We used spacer oligo-
nucleotide typing (spoligotyping) and 
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mycobacterial interspersed repetitive 
units–variable number tandem repeat 
(MIRU-VNTR) methods to investi-
gate human TB caused by M. bovis in 
Taiwan.
During 2004–2005, a total of 
3,321 mycobacteria isolates from in-
dividual patients were sent to the ref-
erence laboratory for strain typing. Of 
the 3,321 patients, 2,427 (73.1%) were 
male, 903 (27.2%) were from eastern 
Taiwan, and 513 (15.4%) were aborig-
inal persons. The mean age of the pa-
tients was 58.7 years: 224 (6.7%) were 
<25 years of age, 667 (20.1%) were 
25–44 years of age, 906 (27.3%) were 
45–64 years of age, and 1,524 (45.9%) 
were >65 years of age. 
Isolates were screened by using a 
GenoType kit (3) and multiplex PCR 
(4). To differentiate between M. bovis 
and M. bovis BCG strains, presence or 
absence of region of difference 1 was 
analyzed (5). Spoligotyping was per-
formed with a commercial kit (Isogen 
Bioscience BV, Maarssen, the Nether-
lands) following the manufacturer’s 
instructions (6). Spoligotyping pro-
ﬁ  les were analyzed by using Bionu-
merics software, version 4.51 (Ap-
plied Maths, Kortijk, Belgium). The 
resolved spoligotype was designated 
by comparing it to SpolDB4 (1). The 
MIRU-VNTR assay was performed 
by using a modiﬁ  ed, high-throughput, 
15-loci MIRU typing system that we 
developed (7).
Of the 3,321 patient isolates, 
3,306 (99.5%) were M.  tuberculosis 
and only 15 (0.5%) were M.  bovis. 
Mean age of the 15 M. bovis–infect-
ed patients was 62.2 years (Table). 
Twelve (80%) patients were male, 
and 3 (20%) were female. Of these 
15 patients, 10 (66.7%) had newly di-
agnosed TB and 5 (33.3%) had been 
treated with anti-TB drugs. Most 
(11/15, 73%) of the patients were from 
eastern Taiwan, where the reporting 
rate for TB was the highest among the 
4 regions of Taiwan; 60% (9/15) were 
aboriginal persons. Of the 15 patients, 
13 (86.7%) had pulmonary TB, 1 had 
both pulmonary and extrapulmonary 
TB, and 1 had extrapulmonary TB. 
Only 2 patients (cases 2 and 3) had 
known contact with farm animals. 
Univariate analysis showed that re-
gion (eastern region 1.2% vs. other re-
gion 0.2%; odds ratio [OR] 7.4, 95% 
conﬁ   dence interval [CI] (2.4–23.4) 
and ethnicity (aboriginal 1.8% vs. 
nonaboriginal 0.2%; OR 8.3, 95% CI 
3.0–23.5) were associated with M. bo-
vis infection but not age and sex. The 
association between region and M. 
bovis disappeared after controlling for 
age and ethnicity. Aboriginal ethnicity 
was the only factor signiﬁ  cantly as-
sociated with TB caused by M. bovis 
after controlling for age (adjusted OR 
12.7, 95% CI 4.2–38.9).
Spoligotyping proﬁ  les of the 15 
M. bovis isolates were typical of M. 
bovis with the absence of spacers 3, 6, 
9, 16, 21, and 39–43 (8). Although 15 
cases were reported separately from 
different regions of Taiwan, only 1 
spoligotyping proﬁ   le was identical 
to spoligotype ST 684 of the bovis 
sublineage. In addition, we identi-
ﬁ  ed 2 similar MIRU-VNTR proﬁ  les: 
523–23232–42533–22 (13/14, 92.9%, 
cases 1–9, 11–13, and 15) and 523–
22232–42523–22 (1/14, 7.1%, case 
14). We were unable to obtain sufﬁ  -
cient DNA from 1 strain (case 10) for 
MIRU-VNTR typing.
Aboriginal persons in Taiwan 
were more likely to have TB caused 
by M. bovis and had a 5-fold higher 
reporting rate for TB (9) than nonab-
original persons. Environmental and 
genetic factors may be associated 
with a higher reporting rate for TB 
among aboriginal populations (10), 
but the contribution of M. bovis infec-
tion needs to be investigated. Because 
only 1 major spoligotype and 2 simi-
lar MIRU patterns were found in this 
case series, spread of a predominant 
clone in Taiwan is likely. In addition, 
because of insufﬁ  cient epidemiologic 
data, we were unable to determine the 
proportion of cases caused by reacti-
vation of latent infection and those 
caused by recent transmission. In our 
study population, M. bovis infection in 
humans appeared to be predominately 
indigenous in Taiwan because no im-
ported case was noted. We are now 
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Table. Characteristics of 15 patients with tuberculosis caused by Mycobacterium bovis, Taiwan, 2004–2005
Patient no.  Age at diagnosis, y  Sex Type of tuberculosis  Ethnicity  Region
1 53 M Pulmonary Aboriginal Northern 
2 71 M Pulmonary Han Central
3 76 M Pulmonary Han Central
4 84 M Pulmonary Han Southern
5 71 F Pulmonary Aboriginal Eastern
6 55 M Pulmonary Aboriginal Eastern
7 51 M Pulmonary Aboriginal Eastern
8 65 F Pulmonary Aboriginal Eastern
9 51 M Pulmonary Han Eastern
10 90 M Pulmonary Han Eastern
11 34 M Pulmonary Aboriginal Eastern
12 81 M Pulmonary Han Eastern
13 64 F Pulmonary Aboriginal Eastern
14 44 M Bladder/urinary Aboriginal Eastern
15 43 M Pulmonary/miliary Aboriginal EasternLETTERS
genotyping  M.  bovis strains isolated 
from farm animals to help elucidate 
the source of infection and transmis-
sion of M. bovis in Taiwan.
Acknowledgments
We thank Chen-Che Chiu and Pei-Ju 
Chin for excellent technical assistance.
This work was supported by grant 
DOH95-DC-2011 from the Taiwan Cen-
ters for Disease Control, Department of 
Health, and joint grant 95-0324-19-F-01-
00-00-00-35 from National Science Coun-
cil and Department of Health, Taiwan, Re-
public of China.
Ruwen Jou,* Wei-Lun Huang,* 
and Chen-Yuan Chiang†
*Centers for Disease Control, Taipei, Tai-
wan, Republic of China; and †International 
Union Against Tuberculosis and Lung Dis-
ease, Paris, France
References
    1.   Brudey K, Driscoll JR, Rigouts L, 
Prodinger WM, Gori A, Al-Hajoj SA, et 
al. Mycobacterium tuberculosis complex 
genetic diversity: mining the fourth in-
ternational spoligotyping database (Spol-
DB4) for classiﬁ  cation, population genet-
ics and epidemiology. BMC Microbiol. 
2006;6:23–39.
    2.    Bureau of Animal and Plant Health In-
spection and Quarantine, Council of Ag-
riculture, Executive Yuan, Taiwan. Annual 
report. Taipei: The Bureau; 2005.
  3.   Richter E, Weizenegger S, Rusch-Gerdes 
S, Niemann S. Evaluation of genotype 
MTBC assay for differentiation of clinical 
Mycobacterium tuberculosis complex iso-
lates. J Clin Microbiol. 2003;41:2672–5.
  4.   Yeboah-Manu D, Yates MD, Wilson SM. 
Application of a simple multiplex PCR to 
aid in routine work of the mycobacterium 
reference laboratory. J Clin Microbiol. 
2001;39:4166–8.
  5.   Behr MA, Wilson MA, Gill WP, Salamon 
H, Schoolnik GK, Rane S, et al. Com-
parative genomics of BCG vaccines by 
whole-genome DNA microarray. Science. 
1999;284:1520–3.
  6.   Kamerbeek J, Schouls L, Kolk A, van Ag-
terveld M, van Soolingen D, Kuijper S, et 
al. Simultaneous detection and strain dif-
ferentiation of Mycobacterium tuberculo-
sis for diagnosis and epidemiology. J Clin 
Microbiol. 1997;35:907–14.
    7.    Chin PJ, Jou R. A modiﬁ  ed  automated 
high-throughput mycobacterial inter-
spersed repetitive unit method for geno-
typing  Mycobacterium tuberculosis. Di-
agn Microbiol Infect Dis. 2005;53:325–7.
  8.   Aranaz A, Lie’bana E, Mateos A, Domin-
guez L, Vidal D, Domingo M, et al. Spacer 
oligonucleotide typing of Mycobacterium 
bovis strains from cattle and other ani-
mals: a tool for studying epidemiology of 
tuberculosis. J Clin Microbiol. 1996;34:
2734–40.
  9.   Hsu YH, Chen CW, Sun HS, Jou R, Lee 
JJ, Su IJ. Association of NRAMP 1 gene 
polymorphism with susceptibility to tu-
berculosis in Taiwanese aboriginals. J 
Formos Med Assoc. 2006;105:363–9.
10.   Wang WH, Chang SJ, Wang TN, Cheng 
LS, Feng YP, Chen CJ, et al. Complex 
segregation and linkage analysis of famil-
ial gout in Taiwanese aborigines. Arthritis 
Rheum. 2004;50:242–6.
Address for correspondence: Ruwen Jou, 
Reference Laboratory of Mycobacteriology, 
Research and Diagnostic Center, Department 
of Health, Centers for Disease Control, 161 
Kun-Yang St, Nan-Kang, Taipei 115, Taiwan, 
Republic of China; email: rwj@cdc.gov.tw
Marine Mammal 
Brucella Genotype 
Associated with 
Zoonotic Infection
To the Editor: Brucellosis is a 
zoonotic disease that remains endemic 
to many parts of the world. There are 
6 classic Brucella species described 
with different preferred hosts. Human 
disease is most commonly associated 
with consumption of unpasteurized 
dairy products or with occupational 
exposure for veterinarians, agricultur-
al workers, laboratory workers, meat 
industry workers, and hunters.
In recent years, it has become 
clear that novel members of the genus, 
yet to be formally named, are associ-
ated with a variety of marine mammal 
species, particularly dolphins, por-
poises, and seals (1). To date there are 
3 reports in the literature of naturally 
acquired infection of humans with 
Brucella species originating from ma-
rine mammals (2,3) One other case, 
representing infection of a laboratory 
worker, has also been reported (4). 
Two of the naturally acquired cases 
were reported in Peru (2). One per-
son had consumed raw shellﬁ  sh and 
swam in the Paciﬁ  c Ocean but did not 
report any direct contact with marine 
mammals; the second person reported 
infrequent visits to the coast and no 
contact with marine mammals but had 
consumed raw shellﬁ  sh. An additional 
naturally acquired case was recently 
reported from New Zealand, where 
extensive molecular testing character-
ized the strain involved as a marine 
mammal type (3). This patient again 
reported no exposure to marine mam-
mals but did report that he ﬁ  shed regu-
larly, had contact with uncooked ﬁ  sh 
bait, and consumed raw snapper. The 
cases in Peru were notable for severe, 
atypical symptoms; both patients had 
symptoms of neurobrucellosis. The 
New Zealand case was associated with 
spinal osteomyelitis (3). In contrast, 
the laboratory-acquired infection was 
mild and uncomplicated (4).
We have characterized these iso-
lates by a variety of molecular ap-
proaches in conjunction with ongoing 
studies, which examine genetic diver-
sity within Brucella species isolated 
from marine mammals. Multilocus se-
quence analysis (5) showed that all 3 
isolates from naturally acquired human 
infection with Brucella species from 
marine mammals shared an identical 
genotype (ST27). In previous charac-
terization of 56 Brucella isolates from 
marine mammals, ST27 was found 
only once. Strain F5/99, originally 
isolated from an aborted bottlenose 
dolphin fetus off the western coast of 
the United States (6), shares this geno-
type. Use of an alternative typing ap-
proach, based on restriction fragment 
length polymorphism analysis of outer 
membrane protein–encoding genes 
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